Jawbone has filed an answer and counterclaim against Fitbit in response to the patent infringement lawsuit that Fitbit filed in early September, according to TechCrunch.
The suit Fitbit filed in September alleged that Jawbone infringed on three patents, two of which were issued in May 2015 and a third that was issued in December 2014. The two from May 2015 were “Notifications On A User Device Based On Activity Detected By An Activity Monitoring Device,” and “Biometric Monitoring Device With Heart Rate Measurement Activated By A Single User Gesture.” The third, issued at the end of last year, was “Methods for Detecting and Recording Physical Activity of Person.” The lawsuit claims Jawbone’s UP Move, UP24, UP2, UP3, and UP4 as well as the UP software interface infringe on these patents.
In the counterclaim that Jawbone filed recently, the company said that Fitbit’s suit was a “meritless patent case” that is “part of its by-any-means-necessary campaign” to slow down its competitors and maintain its position as the dominant fitness tracking device company.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas